T cells: Costimulatory Receptors

T cell activation requires engagement of both the T cell receptor and a co-stimulatory molecule. Lack of a co-stimulatory signal can result in T cell anergy, deletion, or immune tolerance. Find the latest research on T cell co-stimulatory receptors here.

April 16, 2021
Open Access

Roles of BTLA in Immunity and Immune Disorders.

Frontiers in Immunology
Zhaochen NingHuabao Xiong
April 16, 2021
Open Access

Methamphetamine facilitates pulmonary and splenic tissue injury and reduces T cell infiltration in C57BL/6 mice after antigenic challenge.

Scientific Reports
Adriana C Hernandez-SantiniLuis R Martinez
April 16, 2021

CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B Cell Malignancies While Sparing a Subset of Normal B Cells.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Raghuveer RanganathanGianpietro Dotti
April 16, 2021
Open Access

mRNA therapeutics in cancer immunotherapy.

Molecular Cancer
Jan D BeckLena M Kranz
April 16, 2021

Immune checkpoint inhibition in classical Hodgkin lymphoma.

Expert Review of Anticancer Therapy
Parmida Sadat PezeshkiNima Rezaei
April 16, 2021

TIGIT and CD155 as Immune-Modulator Receptor and Ligand on CD4+ T cells in Preeclampsia Patients.

Immunological Investigations
Amin KamraniMehdi Yousefi
April 16, 2021
Open Access

CD4-Targeted T Cells Rapidly Induce Remissions in Mice with T Cell Lymphoma.

BioMed Research International
Jie ChengYi Wang
April 14, 2021
Open Access

Narrative review: update on immunotherapy and pathological features in patients with bladder cancer.

Translational Andrology and Urology
Gaetano AurilioRodolfo Montironi
April 14, 2021
Open Access

Innate immune checkpoint inhibitors: the next breakthrough in medical oncology?

Molecular Cancer Therapeutics
Robert W LentzWells A Messersmith
April 14, 2021

Hspa8 and ICAM-1 as damage-induced mediators of γδ T cell activation.

Journal of Leukocyte Biology
Margarete D JohnsonWendy L Havran
April 14, 2021
Open Access

Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10.

The Journal of Clinical Investigation
Avi MaimonTal Burstyn-Cohen
April 12, 2021

Potent antitumor effect of T cells armed with anti-GD2 bispecific antibody.

Pediatric Blood & Cancer
Miho NakajimaNai-Kong V Cheung

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2021 Meta ULC. All rights reserved